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Objectives: 
To assess efficacy ofoctyl-cyanoacrylate dermabond adhesive glue versus vicryl 3/0 suture for the closure of 
caesarean section skin incision in UKMMC. 
 
Methods: 
This is a prospective randomised controlled trial conducted at a tertiary hospital on 82 women who underwent 
caesarean section. The study group, 41 women underwent dermabond skin closure whereas the control group, 41 
women had subcuticular vicryl skin closure. Anaesthesia, prophylactic antibiotic, operative technique and post-
operative oral analgesia was standardised between both groups. Outcomes that were measured at day 2 before 
discharge and at postoperative day 10-14 were pain score using VAS,  duration and total analgesic dose (after day 2),  
time taken for skin closure and  adverse events between both groups in particular inflammation, surgical site 
infection and allergic reaction (itching). 
 
Results: 
Pain score at Day 2 were similar between both groups (4.0 vs 5.0, p=0.09) whereas pain score at Day 10-14 was 
significantly lower in dermabond skin closure (2.0 vs 4.0, p=<0.001).  Median duration (after day 2) of use of oral 
analgesia among dermabond skin closure group was  4 days and 6 days among subcuticular vicryl skin closure 
group, the difference was statistically significant (p=<0.001). The median amount of additional analgesia required 
was a third less in the dermabond adhesive group as compared to control. Operative time skin closure was 
significantly faster in the dermabond skin closure group with mean difference of 97.7 seconds (170.8 vs 268.5, 
p=<0.001). At day 10-14, wound inflammation, surgical site infection and itching were similar in both groups. 
 
Conclusion: 
Dermabond adhesive glue may be safely used for closure of caesarean section skin incision. It is efficacious, less 
painful, faster application and needing lower analgesic dose with similar adverse events. 
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